Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Sciences|October 29, 2020
Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic ShockMikko Hänninen, Toni Jäntti, Heli Tolppanen, et al.
Resuscitation|September 27, 2016
High-sensitivity troponin-T as a prognostic marker after out-of-hospital cardiac arrest - A targeted temperature management (TTM) trial substudyPatrik Gilje, Sasha Koul, Jakob Hartvig Thomsen, et al.
Thrombosis and Haemostasis|March 11, 2008
C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytesDidier Hanriot, Gaëlle Bello, Armelle Ropars, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 13, 2008
Reverse remodelling through exercise training is more pronounced in non-ischemic heart failureCharles Delagardelle, Patrick Feiereisen, Michel Vaillant, et al.
Theranostics|August 19, 2017
Incremental Value of Circulating MiR-122-5p to Predict Outcome after Out of Hospital Cardiac ArrestYvan Devaux, Antonio Salgado-Somoza, Josef Dankiewicz, et al.
Frontiers in Genetics|June 10, 2021
N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal ToxicitySara B Fernandes, Nathalie Grova, Sarah Roth, et al.
International Journal of Molecular Sciences|July 16, 2020
Approaching Sex Differences in Cardiovascular Non-Coding RNA ResearchAmela Jusic, Antonio Salgado-Somoza, Ana B Paes, et al.
Atherosclerosis|July 15, 2025
Multiomics in atherosclerotic cardiovascular diseaseLiv Tybjærg Nordestgaard, Brooke N Wolford, David de Gonzalo-Calvo, et al.
Critical Care (London, England)|April 30, 2020
Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trialJoachim Düring, Martin Annborn, Tobias Cronberg, et al.
Cardiovascular Research|October 14, 2021
Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: a position paper from the EU-CardioRNA COST action CA17129Maarten Vanhaverbeke, Ritienne Attard, Monika Bartekova, et al.
Pageof 20